Home > News > Monday's Health Winners & Losers
July 2nd, 2007
Monday's Health Winners & Losers
Small-cap bio-nanotech company pSivida (PSDV - Cramer's Take - Stockpickr) took off in the opposite direction after announcing that it entered an agreement for a direct offering to sell its Nasdaq-traded American Depositary Shares and warrants to purchase ADSs, including $6.5 million, to Pfizer (PFE - Cramer's Take - Stockpickr - Rating).
It estimates the net proceeds from the offering will be $16.3 million after the placement agent fees and estimated offering expenses. Shares of pSivida were down 32 cents, or 21%, to $1.20.
Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015
Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Discovery Channel taps Angstron Materials for segment featuring graphene advances January 29th, 2015
Asteroid Mining 101: A New Book by World-Renowned Expert Dr. John S. Lewis - Exclusive Sneak-Peek Opportunity for Book Reviewers and Media January 29th, 2015
Los Alamos Develops New Technique for Growing High-Efficiency Perovskite Solar Cells: Researchers’ crystal-production insights resolve manufacturing difficulty January 29th, 2015
Iranian Scientists Use MOFs to Eliminate Dye Pollutants January 29th, 2015